Kunlun Capital

Kunlun Capital is an investment firm.

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Industries / Tags:

Detailed Kunlun Capital Information

Geographic Data

Kunlun Capital headquarters map

Address:

City:

State:

Zip:

Country:

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Kunlun Capital is a value-oriented and fundamentally driven family office. We do not manage external funds.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
10/2021 Danwang Medical Series A 18.6M
4/2021 EdiGene Series B 61.6M
12/2021 Zhongke Digital Series A -
3/2022 UniXell Seed Round 0
12/2021 CirCode Seed Round 20M
4/2022 Ningbo Shanshan Post-IPO Equity 0
12/2021 Circular Code Biology Seed Round 20M
12/2020 NeoCura Series A 38.2M
3/2021 Nice Tuan Series D 0
3/2022 CellOrigin Biotech Venture Round 0
5/2022 Hui-Gene Therapeutics Series C -
8/2021 UniXell Angel Round -
3/2022 Nutshell Therapeutics Series A 0
12/2021 Zhongke Digital Series A -
3/2021 Biotheus Series B -
5/2022 Hui-Gene Therapeutics Series C -
4/2022 Ningbo Shanshan Post-IPO Equity 0
3/2022 CellOrigin Biotech Venture Round 0
3/2022 Nutshell Therapeutics Series A 0
3/2022 UniXell Seed Round 0
12/2021 Zhongke Digital Series A -
12/2021 Circular Code Biology Seed Round 0
12/2021 CirCode Seed Round 0
10/2021 Danwang Medical Series A 0
8/2021 UniXell Angel Round -

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research